Government strengthens support for melanoma patients
Two breakthrough melanoma treatment options have been added to the Pharmaceutical Benefits Scheme (PBS) to bring hope to over 2000 Australians with advanced melanoma. On March 1 the current PBS listing of Opdivo ® (nivolumab) will be expanded to include adjuvant treatment of IIIB, IIIC, IIID and stage IV malignant melanoma. Federal Member for Bonner…